Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > 2 conferences upcoming: Friday and Tuesday

<< Previous

Bullboard Posts

Next >>

Comment by poolllon Jun 09, 2022 9:20am

80 Views

Post# 34743106

RE:2 conferences upcoming: Friday and Tuesday

GM to launch production of Chevrolet Tracker SUV in Argentina in July

A GM spokesman said the meeting "was a good opportunity today to update the government of Argentina on the progress of this important program and the economic benefit it will deliver to the country."

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario